Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Ideaya Biosciences is a precision medicine oncology company developing targeted small molecule therapeutics and companion diagnostics for genetically defined cancers. Its pipeline includes clinical-stage candidates targeting PKC, MAT2A, DLL3, Pol Theta Helicase, PARG, and KAT6/7, with a focus on biomarker-driven patient populations. The company collaborates with leading pharma firms, owns extensive proprietary platforms, and aims to address unmet needs in cancer treatment through innovative, targeted therapies.
This description was generated via AI from an annual report. Updated about 1 year ago.